US FDA Likely To Embrace In-Person, Remote Combo For Facility Inspections Going Forward
You may also be interested in...
Unannounced facility visits also were to start again in China, but FDA Commissioner Robert Califf said they have been delayed by the COVID-19 outbreak in the country.
Some lawmakers want FDA to prioritize in-person visits, but others are complaining that more remote inspections are needed because approvals are being delayed.
Agency hints of a “hybrid” future of in-person inspections supplemented by alternative tools like remote interactive evaluations.